Literature DB >> 7023381

Activity of ceftazidime (GR 20263) against nosocomially important pathogens.

J M Hamilton-Miller, W Brumfitt.   

Abstract

Ceftazidime was considerably more active than cefuroxime against 180 strains of resistant species of nosocomial gram-negative bacteria. In terms of antibacterial spectrum and intrinsic activity, ceftazidime is an improvement upon existing beta-lactam antibiotics in clinical use and can be regarded as a possible alternative to gentamicin.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7023381      PMCID： PMC181609          DOI： 10.1128/AAC.19.6.1067

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.

Authors:  J M Hamilton-Miller; W Brumfitt; A V Reynolds
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

2.  Homotypic and heterotypic interfering activity associated with measles and subacute sclerosing panencephalitis viruses.

Authors:  P Gardner; J V Bennett; J P Burke; J E McGowan; R P Wenzel
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

3.  Diminished effect of gentamicin under anaerobic or hypercapnic conditions.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

4.  Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery.

Authors:  G L Archer; M J Tenenbaum
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

5.  GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.

Authors:  C H O'Callaghan; P Acred; P B Harper; D M Ryan; S M Kirby; S M Harding
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

6.  GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

7.  Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191
  7 in total
  2 in total

1.  The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

Authors:  A von Graevenitz; C Bucher
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

2.  Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.

Authors:  W Paulfeuerborn; H J Müller; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.